Sodium Bicarbonate Injection — FDA Drug Shortage

Current — Exela Pharma Sciences, LLC

The FDA lists a drug shortage record for Sodium Bicarbonate Injection (injection) from Exela Pharma Sciences, LLC with status Current. The shortage was first posted on Jul 24, 2017.

Shortage details

Status
Current
Company
Exela Pharma Sciences, LLC
Package NDC
51754-5011-4
Dosage Form
Injection
Presentation
Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5011-4)
Initial Posting
Jul 24, 2017

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.